Insights

Innovative Diagnostic Solutions Progenity's application of multi-omics technologies in molecular testing and its development of ingestible diagnostic devices present opportunities to collaborate on advanced diagnostic platforms or personalized medicine solutions tailored for specific patient populations.

Gastrointestinal Focus With recent developments in oral biotherapeutics targeting gastrointestinal conditions like ulcerative colitis, there is potential to offer complementary therapies, supportive diagnostics, or targeted delivery systems to enhance treatment efficacy.

Investing in R&D The company's ongoing innovation in single-molecule detection and patent filings suggest a commitment to cutting-edge technologies, creating prospects to supply research tools, reagents, or supporting software solutions that align with their developmental pipelines.

Recent Strategic Moves Progenity's divestiture of assets and recent funding rounds indicate an evolving corporate strategy, providing openings to offer specialized consulting, licensing, or partnership opportunities to support their next growth phase.

Market Expansion Potential As a biotech company with a focus on precise, personalized healthcare, Progenity's market positioning and recent innovations suggest potential avenues for sales of diagnostic kits, therapeutic delivery systems, or companion diagnostics that complement their pipeline and market needs.

Progenity, Inc. Tech Stack

Progenity, Inc. uses 8 technology products and services including Akamai, Font Awesome, React, and more. Explore Progenity, Inc.'s tech stack below.

Akamai

Content Delivery Network

Font Awesome

Font Scripts

React

Javascript Frameworks

spin.js

Javascript Frameworks

Modernizr

Javascript Libraries

Pantheon

Platform As A Service

Nginx

Web Servers

Facebook

Widgets

Progenity, Inc. Email Formats	Example	Percentage
First.Last@progenity.com	John.Doe@progenity.com	97%
First.Middle@progenity.com	John.Michael@progenity.com	1%
FirstLa@progenity.com	JohnDo@progenity.com	1%
Last.First@progenity.com	Doe.John@progenity.com	1%

Progenity, Inc. Email Formats

Example

Percentage

First.Last@progenity.com

John.Doe@progenity.com

97%

First.Middle@progenity.com

John.Michael@progenity.com

FirstLa@progenity.com

JohnDo@progenity.com

Last.First@progenity.com

Doe.John@progenity.com

Frequently Asked Questions

Where is Progenity, Inc.'s headquarters located?

Progenity, Inc.'s main headquarters is located at 4330 la Jolla Village Drive San Diego, California 92122 United States. The company has employees across 3 continents, including North AmericaAsiaEurope.

What is Progenity, Inc.'s stock symbol?

Progenity, Inc. is a publicly traded company; the company's stock symbol is BIOR.

What is Progenity, Inc.'s official website and social media links?

Progenity, Inc.'s official website is progenity.com and has social profiles on LinkedIn.

What is Progenity, Inc.'s SIC code NAICS code?

Progenity, Inc.'s SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does Progenity, Inc. have currently?

As of December 2025, Progenity, Inc. has approximately 180 employees across 3 continents, including North AmericaAsiaEurope. Key team members include Chief Executive Officer: T. S.Chief Financial Officer: S. A.Vice President Head Of Revenue Cycle Management: D. W.. Explore Progenity, Inc.'s employee directory with LeadIQ.

What industry does Progenity, Inc. belong to?

Progenity, Inc. operates in the Biotechnology Research industry.

What technology does Progenity, Inc. use?

Progenity, Inc.'s tech stack includes AkamaiFont AwesomeReactspin.jsModernizrPantheonNginxFacebook.

What is Progenity, Inc.'s email format?

Progenity, Inc.'s email format typically follows the pattern of First.Last@progenity.com. Find more Progenity, Inc. email formats with LeadIQ.

How much funding has Progenity, Inc. raised to date?

As of December 2025, Progenity, Inc. has raised $20M in funding. The last funding round occurred on Oct 04, 2021 for $20M.

Progenity, Inc.

Q: What is Progenity, Inc.'s official website and social media links?

Progenity, Inc.'s official website is progenity.com. Progenity, Inc. has social profiles on LinkedIn.

Q: How many employees does Progenity, Inc. have currently?

Progenity, Inc. has approximately 180 employees.

Q: What technology does Progenity, Inc. use?

Progenity, Inc.'s tech stack includes Adobe Tag Manager, Pardot, Modernizr, Altium, yepnope.js.

Biotechnology ResearchCalifornia, United States51-200 Employees

Progenity, Inc. is a biotechnology company innovating in the fields of women’s health, gastrointestinal health, and oral biotherapeutics. Progenity applies a multi-omics approach, combining genomics, epigenomics, proteomics, and metabolomics to its molecular testing products and to the development of a suite of investigational ingestible devices designed to provide precise diagnostic sampling and drug delivery solutions. Progenity’s vision is to transform healthcare to become more precise and personal by improving diagnoses of disease and improving patient outcomes through localized treatment with targeted therapies.

Insights

Similar companies to Progenity, Inc.

Laboratory Corporation of America Holdings

Progenity, Inc. Tech Stack

Media & News

Progenity, Inc. is developing PGN-600 program.

Progenity, Inc. sold assets to Nwpathology in the amount of $10.9M on Dec 20th '21.

Progenity, Inc. launched patent related to single-molecule detection platform on Dec 2nd '21.

Progenity, Inc. hired Adi Mohanty as Chief Executive Officer on Nov 8th '21.

Progenity, Inc. hired Jill Howe on Nov 3rd '21.

Harry Stylli left Progenity, Inc. as member and Chairman of the Board of Directors on Sep 1st '21.

Progenity, Inc. went public on Jun 1st '20.

Progenity, Inc.'s Email Address Formats